Esperion Therapeutis.Inc. buy daimler1
Start price
28.04.24
/
50%
€1.83
Target price
28.04.25
-
Performance (%)
11.37%
Price
10.05.24
€2.04
Summary
This prediction is currently active. The BUY prediction by daimler1 currently has a performance of 11.37%. This prediction currently runs until 28.04.25. The prediction end date can be changed by daimler1 at any time. daimler1 has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Esperion Therapeutis.Inc. | 5.214% |
| iShares Core DAX® | 4.094% |
| iShares Nasdaq 100 | 1.424% |
| iShares Nikkei 225® | -1.572% |
| iShares S&P 500 | 1.822% |
Comments by daimler1 for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
Buy Esperion Therapeutis.Inc.
Stopped prediction by daimler1 for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.37
11.05.23
11.05.23
-
11.05.24
11.05.24
-2.77%
15.05.23
15.05.23
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€3.09
06.02.22
06.02.22
-
06.02.23
06.02.23
8.63%
20.02.22
20.02.22
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€10.54
05.09.21
05.09.21
-
05.09.22
05.09.22
1.47%
19.09.21
19.09.21